Price Performance
- Day's Low
- ₹917.3
- Day's High
- ₹942
₹ 923.8
- 52-w low
- ₹423.95
- 52-w high
- ₹974
923.8
- Day's open
₹938.5 - Previous close
₹939.650024 - VWAP
₹923.44 - Lower price band
₹845.7 - Upper price band
₹1,033.60
Today's Market Action
The last traded share price of Glenmark Pharmaceuticals Ltd was 923.80 down by -1.69% on the NSE. Its last traded stock price on BSE was 924.00 down by -1.61%. The total volume of shares on NSE and BSE combined was 357,044 shares. Its total combined turnover was Rs 32.97 crores.
Medium and Long Term Market Action
Glenmark Pharmaceuticals Ltd hit a 52-week high of 974 on 11-03-2024 and a 52-week low of 423.95 on 24-03-2023.
The stock price of Glenmark Pharmaceuticals Ltd is up by 16% over the last one month. It is up by 109.48% over the last one year. Don't forget to check the full stock price history in the table below.
Fundamentals
-
Market Cap (Cr): 26516
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About
Data not available.
FAQ's
What is Share Price of Glenmark Pharmaceuticals Ltd?
What is the Market Cap of Glenmark Pharmaceuticals Ltd?
What is PE Ratio of Glenmark Pharmaceuticals Ltd?
What is PB Ratio of Glenmark Pharmaceuticals Ltd?
What is the CAGR of Glenmark Pharmaceuticals Ltd?
How to Buy Glenmark Pharmaceuticals Ltd Share?
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
Pros
Momentum Strength
Above Average Sustainable RoE
High Shareholder Pedigree
Cons
Low Return on Capital Employed
Poor Cash Flow Conversion
Low Interest Coverage
Highly Cyclical Industry
Capital Intensive Business
Poor Working Capital Cycle
Valuation Analysis
Margin of safety
(19/03/2024)
(19/03/2024)
92
78.57%
78.57% People are bullish about Glenmark Pharmaceuticals Ltd
21.43%
21.43 % People are bearish about Glenmark Pharmaceuticals Ltd